177 related articles for article (PubMed ID: 37936709)
81. Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
Yang J; Lee KW; Baek JY; Bae S; Lee YH; Kim H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR; Park JB; Kim SH; Kim TJ; Kim DM; Ko JH
Am J Transplant; 2023 Apr; 23(4):565-572. PubMed ID: 36739177
[TBL] [Abstract][Full Text] [Related]
82. Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity.
Choi MJ; Heo JY; Seo YB; Yoon YK; Sohn JW; Noh JY; Cheong HJ; Kim WJ; Choi JY; Kim HJ; Lee YJ; Lee HW; Kim SS; Kim B; Song JY
Front Immunol; 2022; 13():1035441. PubMed ID: 36700198
[TBL] [Abstract][Full Text] [Related]
83. A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort.
Yang M; Meng Y; Hao W; Zhang J; Liu J; Wu L; Lin B; Liu Y; Zhang Y; Yu X; Wang X; Gong Y; Ge L; Fan Y; Xie C; Xu Y; Chang Q; Zhang Y; Qin X
Int Immunopharmacol; 2024 Apr; 131():111829. PubMed ID: 38489974
[TBL] [Abstract][Full Text] [Related]
84. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
[TBL] [Abstract][Full Text] [Related]
85. A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China.
Xu R; Zhao B; Lan L; Liu Y; Li Y; Jiang L; Dai S
Int J Med Sci; 2022; 19(7):1122-1130. PubMed ID: 35919814
[No Abstract] [Full Text] [Related]
86. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
87. Cellular Immunity-The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination.
Primorac D; Brlek P; Matišić V; Molnar V; Vrdoljak K; Zadro R; Parčina M
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335076
[TBL] [Abstract][Full Text] [Related]
88. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].
Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E
Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653
[TBL] [Abstract][Full Text] [Related]
89. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
[TBL] [Abstract][Full Text] [Related]
90. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.
Lu W; Yang L; Li X; Sun M; Zhang A; Qi S; Chen Z; Zhang L; Li J; Xiong H
BMC Pediatr; 2021 Apr; 21(1):181. PubMed ID: 33865340
[TBL] [Abstract][Full Text] [Related]
91. Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients - a single-centered study from Pakistan.
Anis S; Khan MA; Fatima A; Kanani F; Aijaz J; Hussain A; Sarfaraz S
Immunol Res; 2023 Dec; 71(6):941-949. PubMed ID: 37436673
[TBL] [Abstract][Full Text] [Related]
92. Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.
Zhang B; Zhou X; Zhu C; Song Y; Feng F; Qiu Y; Feng J; Jia Q; Song Q; Zhu B; Wang J
Front Mol Biosci; 2020; 7():157. PubMed ID: 32719810
[No Abstract] [Full Text] [Related]
93. Clinical Course, Therapeutic Management and Outcome of Coronavirus Disease in Patients With Inborn Errors of Immunity: A Retrospective Multicenter Experience From Iran.
Karimi A; Jamee M; Shokri Y; Heidari A; Nazarpack F; Fallahi M; Shiari R; Li PH; Sharifinejad N; Sharafian S; Mahdaviani SA; Mansouri D; Zeinali A; Alyasin S; Chavoshzadeh Z;
Pediatr Infect Dis J; 2023 Dec; 42(12):1102-1106. PubMed ID: 37751625
[TBL] [Abstract][Full Text] [Related]
94. Prolonged SARS-CoV-2 T Cell Responses in a Vaccinated COVID-19-Naive Population.
Pitiriga VC; Papamentzelopoulou M; Konstantinakou KE; Vasileiou IV; Konstantinidis AD; Spyrou NI; Tsakris A
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543904
[TBL] [Abstract][Full Text] [Related]
95. Early decrease in blood lymphocyte count is associated with poor prognosis in COVID-19 patients: a retrospective cohort study.
Chen G; Zhao X; Chen X; Liu C
BMC Pulm Med; 2023 Nov; 23(1):453. PubMed ID: 37986163
[TBL] [Abstract][Full Text] [Related]
96. Hematological parameters to predict post-COVID-19 immune response among vaccinated and nonvaccinated individuals: a retrospective cross-sectional study.
Khan QA; Atta T; Tango T; Mumtaz A; Saravanan P; Vallabhaneni SH; Shinwari IK; Vattikuti B; Jan R; Verma R; Sami N; Farrukh AM; Levin-Carrion Y
Ann Med Surg (Lond); 2024 Jun; 86(6):3330-3336. PubMed ID: 38846900
[TBL] [Abstract][Full Text] [Related]
97. Disturbance of Adaptive Immunity System Was Accompanied by a Decrease in Plasma Short-Chain Fatty Acid for Patients Hospitalized During SARS-CoV-2 Infection After COVID-19 Vaccination.
Liang Z; Wang N; Fan C; Shang L; Zhang Y; Gao C; Luo J
J Inflamm Res; 2023; 16():5261-5272. PubMed ID: 38026252
[TBL] [Abstract][Full Text] [Related]
98. Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs.
Devi P; Kumari P; Yadav A; Tarai B; Budhiraja S; Shamim U; Pandey R
PLoS Pathog; 2023 Feb; 19(2):e1011160. PubMed ID: 36800345
[TBL] [Abstract][Full Text] [Related]
99. Relationship of various COVID-19 antibody titer with individual characteristics and prediction of future epidemic trend in Xiamen City, China.
Xu L; Abudunaibi B; Zeng Z; Zhao Y; Wang Y; Guo X; Zhang Y; Li T; Lu W; Tian W; Guo Z; Su C; Chen T
J Thorac Dis; 2024 Apr; 16(4):2404-2420. PubMed ID: 38738254
[TBL] [Abstract][Full Text] [Related]
100. Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals.
Berger L; Wolf J; Kalbitz S; Kellner N; Lübbert C; Borte S
Diagnostics (Basel); 2024 Jun; 14(12):. PubMed ID: 38928701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
